Pregnant Elite Athletes and Pregnant Women Exercising With Moderate Intensity

NCT05042349 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-11-13

No results posted yet for this study

Summary

The aim of this study is to 1. register possible changes to uteroplacental circulation in relation to physical tests, 2. to register energy and nutritional intake, relationship towards the body during pregnancy and during the early period after giving birth, 3. register the experience of guidance given related to exercise, nutrition, and recovery, 4. register elite athletes' experience of combining the role of being a mom and an elite athlete, and 5. register attitudes and reactions from the support system when it comes to being an elite athlete and being pregnant. Material and method: 30 pregnant female elite athletes and 30 moderately physically active pregnant women will be recruited for the completion of physical testing and questionnaires and questionnaires only, respectively. 20 national team leaders/coaches and 10 sponsors will be recruited for a semi-structured interview about attitudes, reactions and guidance towards athletes who become pregnant and still wish to continue their career as an athlete after pregnancy.

Conditions

  • Body Image
  • Physical Activity
  • Exercise
  • Energy Intake
  • Nutritional Status
  • Pregnancy Related
  • Fetus Risk
  • Blood Flow
  • Body Temperature

Sponsors & Collaborators

  • Norwegian School of Sport Sciences

    lead OTHER

Principal Investigators

  • Jorunn Sundgot-Borgen, PhD · The Norwegian School of Sport Sciences

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2025-05-01
Completion
2025-05-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05042349 on ClinicalTrials.gov